Close menu

Contact

Products

Labelled Ipilimumab-like 13C15N

Application

Absolute quantification of
Yervoy® or its biosimilars

Specific labelling

Arginine: 13C6,15N4, >99%

Lysine: 13C6,15N2, >99%

Description

Ipilimumab, a recombinant human monoclonal antibody (IgG1 kappa immunoglobin), is an antineoplastic agent developed by Bristol-Myers Squibb and Medarex for the treatment of unresectable or metastatic melanoma in adults. The average weight of Ipilimumab is 148kDa. The labelled Ipilimumab-like stable isotope labelled standard is suited for quantification of Ipilimumab in human serum samples.

 

The mAb-like technology is patented.

This product is for research use only and is not intended for diagnostic or therapeutic use.

10 µg     >    650 €